Obesity medicine provider-directed health coaching in a commercial weight loss program: Proof of concept [0.03%]
商业减肥项目中肥胖医学提供者指导的健康辅导：概念验证
Michelle Alencar,Angela Fitch,Rachel M Sauls et al.
Michelle Alencar et al.
Background: Obesity remains a leading serious chronic disease and cause of death in the U.S. Despite previous research in diets (i.e., caloric restriction), physical activity levels, and biochemical markers, no studies to...
Effective medical treatment of obesity among immigrant women in primary care [0.03%]
移民女性肥胖症的药物治疗有效吗？一项初级诊疗中的研究
Wudeneh M Mulugeta
Wudeneh M Mulugeta
Background: The prevalence of obesity among the general US adults is 42 %. With increasing immigrant population in the US, the obesity burden among immigrants in the US has been reported to approach or exceed that of the ...
"Metabolic surgery in Asian patients with type 2 diabetes mellitus and body mass index less than 30kg/m2: A systematic review" [0.03%]
代谢手术治疗亚洲BMI小于30的2型糖尿病患者系统评价研究
Angel Alois Osorio Manyari,Azucena Lirio Armas Alvarez,Joel Davis Osorio Manyari et al.
Angel Alois Osorio Manyari et al.
Background: The effect of metabolic surgery on long-term diabetes remission in Asian patients with a body mass index (BMI) < 30 kg/m2 has not been widely reported. ...
Relationship of visceral adiposity index (VAI) and visceral body fat among metabolically obese normal weight individuals from Pakistan [0.03%]
巴基斯坦代谢性肥胖正常体重人群的内脏脂肪指数（VAI）与体内脂肪的关系研究
Faisal Ishfaq,Somia Iqtadar,Sidrah Lodhi et al.
Faisal Ishfaq et al.
Background: An increasing number of people throughout the world are suffering with visceral obesity. Accumulation of visceral fat is a pathogenic manifestation of global fat dysfunction, that leads to inflammation, athero...
Optimizing nutrition, diet, and lifestyle communication in GLP-1 medication therapy for weight management: A qualitative research study with registered dietitians [0.03%]
GLP-1减肥治疗中的营养、饮食和生活方式的交流优化：注册营养师定性研究
David Despain,Brenda L Hoffman
David Despain
Background: This qualitative study used semi-structured interviews to examine registered dietitians' perspectives on diet, nutrition, and lifestyle communication for patients on GLP-1 medications for obesity management. ...
Efficacy of in-person versus digital enhanced lifestyle interventions in adults with overweight and obesity [0.03%]
面对面生活方式干预与数字化增强生活方式干预治疗超重和肥胖成人疗效的meta分析
Diego Anazco,Maria A Espinosa,Lizeth Cifuentes et al.
Diego Anazco et al.
Background: Lifestyle interventions (LIs) are the cornerstone for obesity management. The Mayo Clinic Diet (MCD) offers two approaches for LIs: the In-Person LI (IPLI) and the Digital Enhanced LI (DELI). The IPLI includes...
Diagnosis and management of metabolic dysfunction- associated steatotic liver disease in South Asians- A clinical review [0.03%]
南亚人代谢功能异常相关性肝脂肪变病的诊断与治疗——临床综述
Prajith Raj Ramesh,Priya Krishnan,Samyuktha Prabu et al.
Prajith Raj Ramesh et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed as nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of obesity and metabolic syndrome. It is mainly caused...
Varalakshmi Niranjan,Jennifer Ozimek
Varalakshmi Niranjan
Background: South Asians are defined as those indigenous to the Indian subcontinent - India, Pakistan, Sri Lanka, Nepal, Maldives, Bhutan, and Bangladesh. This ethnic group is a unique population with increased prevalence...
Case Reports
Obesity pillars. 2024 Oct 1:12:100137. DOI:10.1016/j.obpill.2024.100137 2024
Obesity in patients with craniopharyngioma in the South Asian region - A distinct phenotype [0.03%]
南亚颅咽管瘤患者的肥胖现象-一种独特的表型特征
Sreevatsa Tatachar,Remya Rajan,Asha Hesaraghatta Shyamsunder et al.
Sreevatsa Tatachar et al.
Background: Craniopharyngiomas are rare benign tumors located in the sellar and suprasellar region, with an incidence of 0.5-2 cases per million as reported in Western studies. Post-treatment, including surgery and/or rad...
Retrospective review of seven patients with obesity simultaneously treated with a combination of a glucagon-like peptide-1 receptor agonist and a meal replacement product [0.03%]
GLP-1受体激动剂与代餐联合治疗肥胖7例回顾分析
Catherine Bacus,Terri-Lynne South,Sonia Raudszus et al.
Catherine Bacus et al.
Background: The use of meal replacement products (MRPs) to obtain a caloric deficit while maintaining micro- and macronutrient requirements, has a long tradition in obesity medicine. Limitations include low compliance, va...